Client
The innovation team of a Fortune 500 life science company was running a long term co-innovation program to learn from and collaborate with technology startups in Asia.
Challenge
The Asian startup ecosystem is highly fragmented and opaque. This makes it difficult to identify high-potential startups before they scale. This is particularly true in fields like neuromorphic computing, where teams may reside in an R&D phase for years before reaching the market.
In order to engage early-stage startups in solution collaboration, the innovation team needed to find entrepreneurs early. They next needed to convince the founding team of the value of collaboration despite differences in working approaches and timelines. Focus domains were diverse, and included digital therapeutics, AI tools for drug discovery, cell and gene therapy tools, process simulation algorithms, and wearable devices to support recovery, among others.